trial · primary record
Norditropin
Healthy Volunteers
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 66 |
| Primary completion | 2014-10-06 |
| Primary endpoint | GH administration may elicit clinical significant and relevant changes in the human immune system |
| Registry ID | NCT00663611 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:30.371Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT00663611
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.